ANI PHARMACEUTICALS, INC Weighted Average Number of Shares Outstanding, Basic and Diluted
ANI PHARMACEUTICALS, INC (ANIP) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 11.97 million shares for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2020-08-06
- ANI PHARMACEUTICALS, INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 11.97M shares, a 0.98% increase year-over-year.
- ANI PHARMACEUTICALS, INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 11.90M shares, a 1.32% increase year-over-year.
- ANI PHARMACEUTICALS, INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-09-30 was 11.88M shares, a 1.48% increase year-over-year.
- ANI PHARMACEUTICALS, INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-06-30 was 11.85M shares, a 1.47% increase year-over-year.
- ANI PHARMACEUTICALS, INC weighted average number of shares outstanding, basic and diluted for fiscal 2013 was 5.07M shares.
- ANI PHARMACEUTICALS, INC weighted average number of shares outstanding, basic and diluted for fiscal 2012 was 0.00 shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-06-30 | 11.97M shares 10-Q · filed 2020-08-06 | 11.94M shares 10-Q · filed 2020-08-06 | ||
| 2020-03-31 | 11.90M shares 10-Q · filed 2020-05-07 | |||
| 2019-09-30 | 11.88M shares 10-Q · filed 2019-11-06 | 11.87M shares derived: average of 2 quarters · filed 2020-08-06 | 11.83M shares 10-Q · filed 2019-11-06 | |
| 2019-06-30 | 11.85M shares 10-Q · filed 2020-08-06 | 11.80M shares 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | 11.75M shares 10-Q · filed 2020-05-07 | |||
| 2018-09-30 | 11.71M shares 10-Q · filed 2019-11-06 | 11.69M shares derived: average of 2 quarters · filed 2019-11-06 | 11.66M shares 10-Q · filed 2019-11-06 | |
| 2018-06-30 | 11.68M shares 10-Q · filed 2019-08-07 | 11.63M shares 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | 11.59M shares 10-Q · filed 2019-05-09 | |||
| 2017-09-30 | 11.55M shares 10-Q · filed 2018-11-06 | 11.54M shares 10-Q · filed 2018-11-06 | ||
| 2013-12-31 | 9.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | 9.51M shares derived: average of 2 quarters · filed 2014-02-28 | 6.73M shares derived: average of 3 quarters · filed 2014-02-28 | 5.07M shares 10-K · filed 2014-02-28 |
| 2013-09-30 | 9.48M shares 10-Q · filed 2013-11-07 | 5.32M shares derived: average of 2 quarters · filed 2013-11-07 | 3.58M shares 10-Q · filed 2013-11-07 | 8.78M shares derived: average of 4 quarters · filed 2014-02-28 |
| 2013-06-30 | 1.16M shares 10-Q · filed 2013-08-09 | 581.85K shares 10-Q · filed 2013-08-09 | 8.55M shares derived: average of 3 quarters · filed 2014-02-28 | 6.41M shares derived: average of 4 quarters · filed 2014-02-28 |
| 2013-03-31 | 24.49M shares 10-Q · filed 2013-05-10 | 12.24M shares derived: average of 2 quarters · filed 2014-02-28 | 8.16M shares derived: average of 3 quarters · filed 2014-02-28 | 6.12M shares derived: average of 4 quarters · filed 2014-02-28 |
| 2012-12-31 | -3.04K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -396.50 shares derived: average of 2 quarters · filed 2014-02-28 | -40.67 shares derived: average of 3 quarters · filed 2014-02-28 | 0.00 shares 10-K · filed 2014-02-28 |
| 2012-09-30 | 2.24K shares 10-Q · filed 2013-11-07 | 1.46K shares derived: average of 2 quarters · filed 2013-11-07 | 1.01K shares 10-Q · filed 2013-11-07 | |
| 2012-06-30 | 671.00 shares 10-Q · filed 2013-08-09 | 389.00 shares 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | 19.38M shares 10-Q · filed 2013-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |